Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection

N. Gablo, K. Trachtova, V. Prochazka, J. Hlavsa, T. Grolich, I. Kiss, J. Srovnal, A. Rehulkova, M. Lovecek, P. Skalicky, I. Berindan-Neagoe, Z. Kala, O. Slaby,

. 2020 ; 9 (8) : . [pub] 20200730

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20021912

Grantová podpora
16-31314A Ministerstvo Zdravotnictví Ceské Republiky

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal and aggressive cancers with a less than 6% five-year survival rate. Circulating microRNAs (miRNAs) are emerging as a useful tool for non-invasive diagnosis and prognosis estimation in the various cancer types, including PDAC. Our study aimed to evaluate whether miRNAs in the pre-operative blood plasma specimen have the potential to predict the prognosis of PDAC patients. In total, 112 PDAC patients planned for surgical resection were enrolled in our prospective study. To identify prognostic miRNAs, we used small RNA sequencing in 24 plasma samples of PDAC patients with poor prognosis (overall survival (OS) < 16 months) and 24 plasma samples of PDAC patients with a good prognosis (OS > 20 months). qPCR validation of selected miRNA candidates was performed in the independent cohort of PDAC patients (n = 64). In the discovery phase of the study, we identified 44 miRNAs with significantly different levels in the plasma samples of the group of good and poor prognosis patients. Among these miRNAs, 23 showed lower levels, and 21 showed higher levels in plasma specimens from PDAC patients with poor prognosis. Eleven miRNAs were selected for the validation, but only miR-99a-5p and miR-365a-3p were confirmed to have significantly lower levels and miR-200c-3p higher levels in plasma samples of poor prognosis cases. Using the combination of these 3-miRNA levels, we were able to identify the patients with poor prognosis with sensitivity 85% and specificity 80% (Area Under the Curve = 0.890). Overall, 3-miRNA prognostic score associated with OS was identified in the pre-operative blood plasma samples of PDAC patients undergoing surgical resection. Following further independent validations, the detection of these miRNA may enable identification of PDAC patients who have no survival benefit from the surgical treatment, which is associated with the high morbidity rates.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20021912
003      
CZ-PrNML
005      
20201204093358.0
007      
ta
008      
201125s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/jcm9082440 $2 doi
035    __
$a (PubMed)32751582
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Gablo, Natalia $u Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic.
245    10
$a Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection / $c N. Gablo, K. Trachtova, V. Prochazka, J. Hlavsa, T. Grolich, I. Kiss, J. Srovnal, A. Rehulkova, M. Lovecek, P. Skalicky, I. Berindan-Neagoe, Z. Kala, O. Slaby,
520    9_
$a Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal and aggressive cancers with a less than 6% five-year survival rate. Circulating microRNAs (miRNAs) are emerging as a useful tool for non-invasive diagnosis and prognosis estimation in the various cancer types, including PDAC. Our study aimed to evaluate whether miRNAs in the pre-operative blood plasma specimen have the potential to predict the prognosis of PDAC patients. In total, 112 PDAC patients planned for surgical resection were enrolled in our prospective study. To identify prognostic miRNAs, we used small RNA sequencing in 24 plasma samples of PDAC patients with poor prognosis (overall survival (OS) < 16 months) and 24 plasma samples of PDAC patients with a good prognosis (OS > 20 months). qPCR validation of selected miRNA candidates was performed in the independent cohort of PDAC patients (n = 64). In the discovery phase of the study, we identified 44 miRNAs with significantly different levels in the plasma samples of the group of good and poor prognosis patients. Among these miRNAs, 23 showed lower levels, and 21 showed higher levels in plasma specimens from PDAC patients with poor prognosis. Eleven miRNAs were selected for the validation, but only miR-99a-5p and miR-365a-3p were confirmed to have significantly lower levels and miR-200c-3p higher levels in plasma samples of poor prognosis cases. Using the combination of these 3-miRNA levels, we were able to identify the patients with poor prognosis with sensitivity 85% and specificity 80% (Area Under the Curve = 0.890). Overall, 3-miRNA prognostic score associated with OS was identified in the pre-operative blood plasma samples of PDAC patients undergoing surgical resection. Following further independent validations, the detection of these miRNA may enable identification of PDAC patients who have no survival benefit from the surgical treatment, which is associated with the high morbidity rates.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Trachtova, Karolina $u Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic.
700    1_
$a Prochazka, Vladimir $u Department of Surgery, Faculty Hospital Brno and Faculty of Medicine, Masaryk University, 601 77 Brno, Czech Republic.
700    1_
$a Hlavsa, Jan $u Department of Surgery, Faculty Hospital Brno and Faculty of Medicine, Masaryk University, 601 77 Brno, Czech Republic.
700    1_
$a Grolich, Tomas $u Department of Surgery, Faculty Hospital Brno and Faculty of Medicine, Masaryk University, 601 77 Brno, Czech Republic.
700    1_
$a Kiss, Igor $u Masaryk Memorial Cancer Institute, Department of Comprehensive Cancer Care, 602 00 Brno, Czech Republic.
700    1_
$a Srovnal, Josef $u Laboratory of Experimental Medicine, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, 771 47 Olomouc, Czech Republic.
700    1_
$a Rehulkova, Alona $u Laboratory of Experimental Medicine, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, 771 47 Olomouc, Czech Republic.
700    1_
$a Lovecek, Martin $u 1st Department of Surgery, Faculty of Medicine and Dentistry, Palacky University and University Hospital 771 47 Olomouc, Czech Republic.
700    1_
$a Skalicky, Pavel $u 1st Department of Surgery, Faculty of Medicine and Dentistry, Palacky University and University Hospital 771 47 Olomouc, Czech Republic.
700    1_
$a Berindan-Neagoe, Ioana $u MEDFUTURE-Research Center for Advanced Medicine, University of Medicine, and Pharmacy Iuliu-Hatieganu, 400000 Cluj-Napoca, Romania.
700    1_
$a Kala, Zdenek $u Department of Surgery, Faculty Hospital Brno and Faculty of Medicine, Masaryk University, 601 77 Brno, Czech Republic.
700    1_
$a Slaby, Ondrej $u Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic. Department of Pathology, Faculty Hospital Brno and Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic. Department of Biology, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic.
773    0_
$w MED00195462 $t Journal of clinical medicine $x 2077-0383 $g Roč. 9, č. 8 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32751582 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201204093356 $b ABA008
999    __
$a ind $b bmc $g 1591620 $s 1112584
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 9 $c 8 $e 20200730 $i 2077-0383 $m Journal of clinical medicine $n J Clin Med $x MED00195462
GRA    __
$a 16-31314A $p Ministerstvo Zdravotnictví Ceské Republiky
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace